Lagos State Governor, Babajide Sanwo-Olu, has reaffirmed his administration’s dedication to the health sector, emphasizing the ongoing commitment to providing accessible and affordable quality healthcare services to the state’s residents.
Governor Sanwo-Olu made this declaration during a courtesy visit to the Lagos House, Marina, by the Minister of State for Health and Social Welfare, Dr. Tunji Alausa.
He congratulated Alausa on his ministerial appointment by President Bola Tinubu, expressing confidence in the minister’s ability to excel in his role and collaborate effectively with state governments and fellow ministers to enhance healthcare service delivery nationwide.
The governor’s statements, released on the state government’s website, included the following: “Our conversation with you has confirmed our preparedness and our level of collaboration with the Federal Government.
We want to assure you that we are willing to collaborate in areas where your expertise can complement all of the things that we are doing so that at the end of it, our people who are the reason why we are in government can feel the benefit of all the interventions that we do.”
He added, “We want to assure you (Dr. Alausa) that Lagos State is more than ready and prepared to come up with various steps that will ensure that health is not only accessible but also affordable.”
Dr. Alausa, in his remarks, underscored the Federal Government’s readiness to support the Lagos State Government and other sub-national entities in delivering affordable and accessible healthcare services to the residents.
He also encouraged the state government to enhance the State Universal Health Insurance policies.
Alausa’s visit to the governor aimed to position Lagos as a role model for other states in the country, aligning with the Renewed Hope agenda of the Tinubu-led administration by providing improved healthcare services.
The minister urged Nigerians, especially females aged nine to 14, to take the Human Papillomavirus vaccine, launched on Tuesday.
He highlighted the vaccine’s safety and effectiveness in preventing cervical cancer by up to 95%.